BIOATLA, INC. Operating Lease, Payments
BIOATLA, INC. (BCAB) reported Operating Lease, Payments of $365.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-13
- BIOATLA, INC. operating lease, payments for the quarter ending 2026-06-30 was $365.00K, a 34.47% decline year-over-year.
- BIOATLA, INC. operating lease, payments for the quarter ending 2026-03-31 was $244.00K, a 15.28% decline year-over-year.
- BIOATLA, INC. operating lease, payments for the quarter ending 2025-12-31 was $122.00K, a 71.29% decline year-over-year.
- BIOATLA, INC. operating lease, payments for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- BIOATLA, INC. operating lease, payments for fiscal 2025 was $967.00K, a 42.61% decline from fiscal 2024.
- BIOATLA, INC. operating lease, payments for fiscal 2024 was $1.69M, a 12.33% increase from fiscal 2023.
- BIOATLA, INC. operating lease, payments for fiscal 2023 was $1.50M, a 3.54% decline from fiscal 2022.
- BIOATLA, INC. operating lease, payments for fiscal 2022 was $1.55M, a 13.17% increase from fiscal 2021.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $365.00K 10-Q · filed 2026-08-13 | $609.00K 10-Q · filed 2026-08-13 | $731.00K derived: sum of 3 quarters · filed 2026-08-13 | $731.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $244.00K 10-Q · filed 2026-05-15 | $366.00K derived: sum of 2 quarters · filed 2026-05-15 | $366.00K derived: sum of 3 quarters · filed 2026-05-15 | $923.00K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $122.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $122.00K derived: sum of 2 quarters · filed 2026-03-31 | $679.00K derived: sum of 3 quarters · filed 2026-08-13 | $967.00K 10-K · filed 2026-03-31 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $557.00K derived: sum of 2 quarters · filed 2026-08-13 | $845.00K 10-Q · filed 2025-11-13 | $1.27M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $557.00K 10-Q · filed 2026-08-13 | $845.00K 10-Q · filed 2026-08-13 | $1.27M derived: sum of 3 quarters · filed 2026-08-13 | $1.70M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $288.00K 10-Q · filed 2026-05-15 | $713.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.14M derived: sum of 3 quarters · filed 2026-05-15 | $1.42M derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $425.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $850.00K derived: sum of 2 quarters · filed 2026-03-31 | $1.13M derived: sum of 3 quarters · filed 2026-03-31 | $1.69M 10-K · filed 2026-03-31 |
| 2024-09-30 | $425.00K 10-Q · filed 2025-11-13 | $704.00K derived: sum of 2 quarters · filed 2025-11-13 | $1.26M 10-Q · filed 2025-11-13 | $1.53M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $279.00K 10-Q · filed 2025-08-07 | $836.00K 10-Q · filed 2025-08-07 | $1.11M derived: sum of 3 quarters · filed 2025-08-07 | $1.52M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $557.00K 10-Q · filed 2025-05-06 | $831.00K derived: sum of 2 quarters · filed 2025-05-06 | $1.24M derived: sum of 3 quarters · filed 2025-05-06 | $1.65M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $274.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $685.00K derived: sum of 2 quarters · filed 2025-03-28 | $1.09M derived: sum of 3 quarters · filed 2025-03-28 | $1.50M 10-K · filed 2025-03-28 |
| 2023-09-30 | $411.00K 10-Q · filed 2024-11-07 | $818.00K derived: sum of 2 quarters · filed 2024-11-07 | $1.23M 10-Q · filed 2024-11-07 | $1.63M derived: sum of 4 quarters · filed 2024-11-07 |
| 2023-06-30 | $407.00K 10-Q · filed 2024-08-08 | $814.00K 10-Q · filed 2024-08-08 | $1.21M derived: sum of 3 quarters · filed 2024-08-08 | $1.61M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $407.00K 10-Q · filed 2024-05-14 | $807.00K derived: sum of 2 quarters · filed 2024-05-14 | $1.21M derived: sum of 3 quarters · filed 2024-05-14 | $1.58M derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | $801.00K derived: sum of 2 quarters · filed 2024-03-26 | $1.18M derived: sum of 3 quarters · filed 2024-03-26 | $1.55M 10-K · filed 2024-03-26 |
| 2022-09-30 | $401.00K 10-Q · filed 2023-11-07 | $778.00K derived: sum of 2 quarters · filed 2023-11-07 | $1.16M 10-Q · filed 2023-11-07 | $1.53M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $377.00K 10-Q · filed 2023-08-01 | $754.00K 10-Q · filed 2023-08-01 | $1.13M derived: sum of 3 quarters · filed 2023-08-01 | $1.50M derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $377.00K 10-Q · filed 2023-05-11 | $748.00K derived: sum of 2 quarters · filed 2023-05-11 | $1.12M derived: sum of 3 quarters · filed 2023-05-11 | $1.43M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $371.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $741.00K derived: sum of 2 quarters · filed 2023-03-23 | $1.06M derived: sum of 3 quarters · filed 2023-03-23 | $1.37M 10-K · filed 2023-03-23 |
| 2021-09-30 | $370.00K 10-Q · filed 2022-11-04 | $686.00K derived: sum of 2 quarters · filed 2022-11-04 | $1.00M 10-Q · filed 2022-11-04 | |
| 2021-06-30 | $316.00K 10-Q · filed 2022-08-09 | $632.00K 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $316.00K 10-Q · filed 2022-05-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |